Patient preferences for allogeneic haematopoietic stem cell transplantation: how much benefit is worthwhile from the patient’s perspective?

Oncological studies have shown that patients consider small benefits sufficient to make adjuvant chemotherapy worthwhile. We sought to determine the minimal survival benefits that patients considered enough to legitimate allogeneic haematopoietic stem cell transplantation (HCT) and the factors assoc...

Descripción completa

Detalles Bibliográficos
Autores principales: Leuthold, Nicolas, Cattaneo, Marco, Halter, Jörg, Hügli, Claudia, Kirsch, Monika, Petropoulou, Anna, Erlanger, Tobias E., Gerull, Sabine, Passweg, Jakob, O’Meara Stern, Alix
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8062338/
https://www.ncbi.nlm.nih.gov/pubmed/33067766
http://dx.doi.org/10.1007/s00520-020-05816-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8062338/
https://www.ncbi.nlm.nih.gov/pubmed/33067766
http://dx.doi.org/10.1007/s00520-020-05816-z

Ejemplares similares